Application 075703
- Type
- ANDA
- Sponsor
- APOTEX INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLEMASTINE FUMARATE | CLEMASTINE FUMARATE | SYRUP;ORAL | EQ 0.5MG BASE/5ML | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A075703-001 | CLEMASTINE FUMARATE | CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | SYRUP / ORAL | 2000-11-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2022-10-28 04:53 UTC | 2022-10 | A075703-001 | CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | SYRUP / ORAL | 2000-11-27 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A075703-001 | CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | SYRUP / ORAL | 2000-11-27 | e64feba35796… | ||
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | A075703-001 | CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | SYRUP / ORAL | 2000-11-27 | cb3db0bc1861… | ||
| 2026-07-26 02:55 UTC · 3 captures of this ZIP | 2026-06 | A075703-001 | CLEMASTINE FUMARATE | EQ 0.5MG BASE/5ML | SYRUP / ORAL | 2000-11-27 | a50c72e98297… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Clemastine Fumarate | CLEMASTINE FUMARATE | Genus Lifesciences | cf8a3449-8bb3-4d5c-8d0d-557590e49ee5 | 2025-02-03 | Warnings, Adverse reactions | Clemastine Fumarate CLEMASTINE FUMARATE |
| Clemastine Fumarate | CLEMASTINE FUMARATE | Genus Lifesciences | 5c99e7af-86a5-4c17-82d5-2d4119e4fe72 | 2024-11-25 | Warnings, Adverse reactions | Clemastine Fumarate CLEMASTINE FUMARATE |
| CLEMASTINE FUMARATE | CLEMASTINE FUMARATE | Chartwell RX, LLC | 6663f1b0-5353-401f-b9d3-d9f69ad08fbf | 2023-07-07 | Warnings, Adverse reactions | CLEMASTINE FUMARATE CLEMASTINE FUMARATE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 8769 | ORIG | 2000-11-27 |